- $103.53m
- $102.10m
- $16.46m
- 46
- 76
- 24
- 47
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 12.7 | 5.01 | 9.3 | 23.6 | 16.5 |
Selling / General / Administrative Expenses | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 0.847 | 1.18 | 0.632 | 1.92 | 1.24 |
Operating Profit | 11.8 | 3.83 | 8.67 | 21.7 | 15.2 |
Net Income Before Taxes | 11.8 | 3.83 | 8.67 | 21.7 | 15.2 |
Net Income After Taxes | 11.8 | 3.83 | 8.67 | 21.7 | 15.2 |
Net Income Before Extraordinary Items | |||||
Net Income | 11.8 | 3.83 | 8.67 | 21.7 | 15.2 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 11.8 | 3.83 | 8.67 | 21.7 | 15.2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.695 | 0.225 | 0.51 | 1.27 | 0.895 |
Dividends per Share |